# my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults

> **NCT07516353** · NA · NOT_YET_RECRUITING · sponsor: **Dana-Farber Cancer Institute** · enrollment: 143 (estimated)

## Conditions studied

- Sarcoma
- Osteosarcoma
- Ewing Sarcoma
- Rhabdomyosarcoma
- Acute Myeloid Leukemia
- Aml
- ALL
- Medulloblastoma
- Acute Lymphoblastic Leukemia ,Lymphomas

## Interventions

- **BEHAVIORAL:** my.naviGATE Digital Tool

## Key facts

- **NCT ID:** NCT07516353
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-20
- **Primary completion:** 2028-12-31
- **Final completion:** 2030-12-31
- **Target enrollment:** 143 (ESTIMATED)
- **Last updated:** 2026-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07516353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07516353, "my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07516353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*